Patent · US Active

Methods for treating lung disorders

US10507181B2 · kind B2 · utility

10Cited by
48References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 18, 2019
Grant dateDec 17, 2019
Priority date
Expiry dateJun 18, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.